Trial Profile
Clinical, Microbiologic and Immunologic Profile of the Periodontal Condition in Hypogonadic Men
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2020
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 14 Apr 2020 Status changed from recruiting to withdrawn prior to enrolment.
- 14 Apr 2020 Planned End Date changed from 31 Dec 2019 to 31 Dec 2020.
- 14 Apr 2020 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2020.